Endoplast ApS: Financial statements 2025
CVR: 40866442
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Endoplast ApS (CVR 40866442) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 168,968 and a net result of DKK 99,945 compared with DKK -19,064 the year before. That is an increase of 545.9% compared with the year before. Equity in the 2025 report amounted to DKK -268,595. The company had 1 employee in the financial year.
- Gross Profit
- DKK 168,968
- Profit/Loss
- DKK 99,945
- Equity
- DKK -268,595
- Total Assets
- DKK 510,318
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 169 t. | 100 t. | -269 t. | 1 |
| 2024 | - | 26 t. | -19 t. | -369 t. | 1 |
| 2023 | - | 111 t. | 54 t. | -349 t. | 0 |
| 2022 | - | -463 t. | -376 t. | -404 t. | 0 |
| 2021 | - | -109 t. | -89 t. | -28 t. | 0 |
Official annual report
How creditworthy is Endoplast ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Endoplast ApS has published its annual report for 2024. Gross profit came to DKK 26,160, and the net result was DKK -19,064.
About Endoplast ApS
Endoplast ApS is a Danish company of the type Anpartsselskab based in Hårlev, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Thomas Foldberg. The company is owned by TACC Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 168,968 and a net result of DKK 99,945 compared with DKK -19,064 the year before. Equity in the 2025 report amounted to DKK -268,595.